Participants were randomly assigned to 2 groups. The perioperative treatment group received pembrolizumab 200mg intravenously (IV) every 3 weeks (Q3W) for 2 cycles, as neoadjuvant therapy prior to ...
Cefpodoxime proxetil 100mg, 200mg; tabs. Susceptible mild to moderate infections including acute otitis media, acute bacterial exacerbations of chronic bronchitis, acute maxillary sinusitis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback